Feedback / Questions
CM355 - Keymed Biosciences, InnoCare, Prolium Bioscience
https://www.businesswire.com/news/home/20250120534760/en/InnoCare-and-KeyMed-Jointly-Announce-the-License-Agreement-with-Prolium-for-CD20xCD3-Bispecific-Antibody-ICP-B02
Jan 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next